Summary & Overview
CPT 64600: Trigeminal Nerve Neurodestructive Injection
CPT code 64600 covers a neurodestructive injection performed at or near the trigeminal nerve to interrupt nerve function for management of severe facial motor dysfunction or intractable trigeminal neuralgia. Nationally, this code represents a targeted interventional procedure used by pain medicine, neurology, and neurosurgery providers to treat debilitating facial pain and select motor disorders when conservative therapies have failed. The procedure has implications for utilization, prior authorization, and coverage policy due to its invasive nature and potential complications.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a clinical context for the procedure, common sites of service, and the payer landscape relevant to authorization and coverage frameworks. The publication also summarizes benchmarks and policy updates affecting coverage determinations, typical billing considerations, and areas of clinical guidance relevant to coding and claims processing.
The content is intended for billing managers, policy analysts, and clinicians seeking a concise reference to CPT code 64600, including clinical purpose, payer coverage patterns, and the types of operational and policy issues that commonly arise when this service is billed.
Billing Code Overview
CPT code 64600 describes the neurodestructive injection of a nerve at or near the trigeminal nerve. This procedure involves the deliberate destruction of part of a cranial nerve using a neurodestructive agent to disrupt nerve function.
-
Service type: Neurodestructive nerve injection for trigeminal nerve management
-
Typical site of service: Outpatient procedural settings such as ambulatory surgery centers or hospital outpatient departments, or specialty clinics where cranial nerve procedures are performed
Clinical & Coding Specifications
Clinical Context
A typical patient is a 65-year-old with a several-month history of severe, lancinating facial pain consistent with trigeminal neuralgia refractory to medical therapy (carbamazepine or oxcarbazepine). The patient is evaluated in a neurosurgery or interventional pain clinic. The workflow includes pre-procedure assessment (history, focused neurologic exam, medication reconciliation, consent), imaging review (MRI to exclude structural causes), peri-procedural planning, and execution in an outpatient procedure suite or ambulatory surgery center. Under monitored anesthesia care or local anesthesia with sedation, the provider locates the trigeminal ganglion or peripheral branches and injects a neurodestructive agent (e.g., glycerol) or performs percutaneous injection to ablate nociceptive fibers. Post-procedure monitoring assesses hemodynamics, neurologic status, and pain relief; discharge instructions cover activity restrictions, wound care if puncture site present, symptom monitoring for facial numbness or weakness, and follow-up for pain control and potential repeat procedures if pain recurs.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
59 | Distinct procedural service | When another distinct procedure not normally reported together is performed on the same day at a different anatomical site or incision. |
24 |